Top Ten Issues in Health Law 2022

September 4, 2026

30th Annual IBA Competition Conference

Axinn is proud to sponsor the International Bar Association’s Annual Competition Conference, being held September 4-5 in Florence, Italy.

Speaking Engagement

Antitrust

July 29, 2026

Women Leaders in Life Sciences Law

Axinn attorneys Denise Plunkett and Rebecca Clegg will speak on panels during the American Conference Institute's 13th Annual Summit for Women Leaders in Life Sciences Law, July 29–30 in Boston, MA.

Speaking Engagement

Litigation & Trials

July 28, 2026

American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives

Axinn Partners Leslie Overton, Dan Matheson, James "Jimmy" Moore, and Associate Anna Van de Stouwe will serve as the roundtable panel during the American Bar Association's Webinar titled "Inside Antitrust Enforcement—Former Government Perspectives."

Webinar

Antitrust

July 28, 2026

What's the Skinny on SCOTUS' Skinny Label Decision?

The Supreme Court’s recent Hikma v. Amarin decision has renewed attention on induced infringement of method-of-use claims in Hatch-Waxman cases. This CLE will contextualize the decision and explore the extent to which it represents a mere refocusing of the law rather than a dramatic shift.

Webinar

Intellectual Property

July 27, 2026

National Bar Association Corporate Counsel Leadership Summit

Panel: What's Going On: Making Sense of AI’s Impact on the Legal Profession and Client Strategies.

Speaking Engagement

Antitrust

July 22, 2026

FTC Prescribes Lower Out-of-Pocket Insulin Costs in Settlement with Caremark

On July 14, 2026, the Federal Trade Commission and Caremark Rx LLC and Zinc Health Services LLC (collectively “Caremark”) reached a...

Axinn Viewpoints

Antitrust

July 20, 2026

The FTC’s Record $12 Million HSR Penalty: Deal Structuring, Avoidance, and the Line Between Them

Parties structure transactions with the HSR Act in mind all the time, and nothing in the Act requires them to make a deal reportable. What parties cannot do, in the FTC's view, is disguise a reportable transaction as a non-reportable one. The FTC's latest enforcement action – and the largest penalty in the HSR Act's history – shows where the agency draws that line and what it now charges for crossing it.

Axinn Viewpoints

Antitrust

July 15, 2026

DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead

On July 15, Axinn Partners James Attridge and Daniel Oakes will speak during the DC Bar's briefing titled "The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead."

Speaking Engagement

Antitrust

July 15, 2026

The ITC's Strategic Reset: One year after Lashify and the revival of Fintiv

The International Trade Commission has undergone a fundamental shift over the past 18 months. New precedent on domestic industry.

Byline Articles

Intellectual Property

July 14, 2026

Axinn Partner John DeQ. Briggs Endows Antitrust Professorship at Georgetown Law

John DeQ. Briggs, a partner at Axinn and founder of the firm’s Washington, D.C. office, has made a significant gift to Georgetown University Law Center to establish the John DeQ. Briggs Endowed Professorship in Antitrust Law.

News

Antitrust

July 14, 2026

Informa Antitrust Midwest 2026

On July 14, Axinn Partner Daniel Matheson will moderate the panel "Antitrust in the Trump 2.0 Administration So Far: Lessons Learned & What's Ahead" at Informa's 2026 Antitrust Midwest Conference.

Speaking Engagement

Antitrust

July 14, 2026

Too Much or Not Enough? Healthcare Organizations Comment on the New HSR Form

In February 2025, the FTC and DOJ announced that a new HSR form was in effect, requiring enhanced disclosures that the agencies claimed...

Axinn Viewpoints

Antitrust

Top Ten Issues in Health Law 2022

Related People

Related Services

Featured Insights

Featured Insights